Ricky Turgeon PharmD (@ricky_turgeon) 's Twitter Profile
Ricky Turgeon PharmD

@ricky_turgeon

CV Pharmacist-Researcher, Assistant Prof @ubcpharmacy EBM & shared decision making enthusiast, all-around nerd.
Slowly moving to rickyturgeon.bsky.social

ID: 2398230380

linkhttp://nerdcat.org calendar_today19-03-2014 17:45:34

4,4K Tweet

1,1K Followers

338 Following

Canadian Cardiovascular Pharmacist Network (@ccpnrx) 's Twitter Profile Photo

Join us virtually at the 23rd Annual CCPN Western Symposium on Saturday, November 23! Agenda at eventbrite.ca/e/the-canadian… Register now!

CMAJ (@cmaj) 's Twitter Profile Photo

Pharmacotherapy in heart failure: Simultaneous initiation of the 4 standard heart failure medications with biweekly adjustment provided the highest cost utility compared with other strategies. ➡️ cmaj.ca/lookup/doi/10.… Ricky Turgeon PharmD UBC Pharm Sci

Gregg Fonarow MD (@gcfmd) 's Twitter Profile Photo

Simultaneous initiation of the 4 standard HFrEF medications with biweekly adjustment provided the highest cost utility compared with other strategies Systems of care are needed to enable rapid initiation and sustained use of HFrEF meds Steve Greene Javed Butler Harriette Van Spall, MD MPH 🇨🇦

CIHR (@cihr_irsc) 's Twitter Profile Photo

The new cohort of the Health System Impact Fellowship is here! 🎉 45 talented researchers will work with 35 health organizations nationwide to drive innovation and tackle Canada's most pressing health issues. canada.ca/en/institutes-… #CIHR_ImpactFellows

The new cohort of the Health System Impact Fellowship is here! 🎉 45 talented researchers will work with 35 health organizations nationwide to drive innovation and tackle Canada's most pressing health issues.

canada.ca/en/institutes-…

#CIHR_ImpactFellows
Ricky Turgeon PharmD (@ricky_turgeon) 's Twitter Profile Photo

If you liked yesterday's CMAJ paper on heart failure sequencing strategies, wait until you see what Blair MacDonald's cooking up next as part of his CIHR HSI fellowship - 'Evaluation of Models of Care for HFrEF Through the Use of a Microsimulation Model'

Ricky Turgeon PharmD (@ricky_turgeon) 's Twitter Profile Photo

Going to #AHA24? Come talk to Blair MacDonald about our latest modeling study of pharmacotherapy for heart failure with reduced ejection fraction, this time looking at 1-year efficacy/safety of different quadruple therapy sequencing strategies: eppro01.ativ.me/appinfo.php?pa…

Craig Baird - Canadian History Ehx (@craigbaird) 's Twitter Profile Photo

When it comes to the Christmas season in French Canada, one dish that is always loved is Tourtière. It is a delicious dish, and its history dates back to the earliest days of New France. Let's learn more about the history of Tourtière :) 🧵1/8

When it comes to the Christmas season in French Canada, one dish that is always loved is Tourtière.
It is a delicious dish, and its history dates back to the earliest days of New France.
Let's learn more about the history of Tourtière :)

🧵1/8
CPhA/APhC (@cphaaphc) 's Twitter Profile Photo

The recording of our December #webinar is now online! ⏯️ Hear from Dr. David Gardner about the current best practice for #insomnia care and explore resources to support your patients: ow.ly/bxJO50UpmXC

The recording of our December #webinar is now online!

⏯️ Hear from Dr. David Gardner about the current best practice for #insomnia care and explore resources to support your patients: ow.ly/bxJO50UpmXC
Mina T. (@mina__t) 's Twitter Profile Photo

Watch our updated top 15 outpatient drug purchases in 🇨🇦 From our updated forecast paper! canjhealthtechnol.ca/index.php/cjht…

CSHP/SCPRS (@cshp_scph) 's Twitter Profile Photo

❣️ Elevate Patient Care with CSHP and Canadian Cardiovascular Pharmacist Network! Gain the tools and insights to deliver exceptional care for patients with ASCVD at the Canadian Pharmacy Atherosclerotic Cardiovascular Disease Symposium. 🎟️: CSHP.ca/ASCVDS

❣️ Elevate Patient Care with CSHP and <a href="/CCPNrx/">Canadian Cardiovascular Pharmacist Network</a>! 

Gain the tools and insights to deliver exceptional care for patients with ASCVD at the Canadian Pharmacy Atherosclerotic Cardiovascular Disease Symposium.

🎟️: CSHP.ca/ASCVDS
Ahmed Bennis (@drbennisahmed) 's Twitter Profile Photo

Evaluation of PHARM-HF, a pharmacist-led heart failure medication titration clinic: A pre-post study Uptake of GDMT significantly increased from admission to discharge from the PHARM-HF medication optimization clinic accpjournals.onlinelibrary.wiley.com/doi/10.1002/ja…

Evaluation of PHARM-HF, a pharmacist-led heart failure medication titration clinic: A pre-post study

Uptake of GDMT significantly increased from admission to discharge from the PHARM-HF medication optimization clinic

accpjournals.onlinelibrary.wiley.com/doi/10.1002/ja…
Arden Barry (@ardenbarry) 's Twitter Profile Photo

Join me at the 2nd Canadian Cardiovascular Pharmacist Network CSHP/SCPRS CVD Symposium--focusing on ASCVD--on Feb 1 (to kick off Heart Month). The program is virtual (and will also be available to view after the event) and fully accredited. #pharmacy #CVD ccs.ca/event/canadian…

CSHP BC Branch (@cshpbcbranch) 's Twitter Profile Photo

We are inviting you to join CSHP and the Canadian Cardiovascular Pharmacists Network this Saturday February 1, 2025 at 10:00 AM EST (or 7:00 AM PST) for a virtual event on an all things related to Atherosclerotic Cardiovascular Disease. More details: cshp.ca/Site/rise/Even…

We are inviting you to join CSHP and the Canadian Cardiovascular Pharmacists Network this Saturday February 1, 2025 at 10:00 AM EST (or 7:00 AM PST) for a virtual event on an all things related to Atherosclerotic Cardiovascular Disease. 

More details: cshp.ca/Site/rise/Even…
Journal of Cardiac Failure (@jcardfail) 's Twitter Profile Photo

Is there finally a verdict on MRAs in HFmrEF/HFpEF? This recent #JCFIgnite! re-examines the data and finds that both steroidal and non-steroidal MRAs may be beneficial 💪 🔗 bit.ly/4hndctr

Is there finally a verdict on MRAs in HFmrEF/HFpEF?   

This recent #JCFIgnite! re-examines the data and finds that both steroidal and non-steroidal MRAs may be beneficial 💪  

🔗  bit.ly/4hndctr
Sanjay Kaul (@kaulcsmc) 's Twitter Profile Photo

David J. Cohen, MD, MSc Davide Capodanno TCTMD PCRonline 🫀 Attributes of ideal NI trial: 90-95% power Margin fixed as relative difference, RR 1.5-1.2 Separate assessment of efficacy & safety Criterion for win: NI efficacy, superior safety NI met with ITT & PP analysis How many NI trials, especially monotherapy vs DAPT trials, meet these?